These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3932550)

  • 1. [Clinical studies on MT-141].
    Yamamoto T; Suzuki K; Kishimoto A
    Kansenshogaku Zasshi; 1985 Jul; 59(7):657-63. PubMed ID: 3932550
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with rational cefotetan therapy in in situ and associated surgical infections].
    Puleo S; Li Destri G; Scuderi M; Sammartino R; Romeo MA; Gismondo MR; Nicoletti G
    Ann Ist Super Sanita; 1987; 23(4):911-3. PubMed ID: 3482980
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of cefotetan in pediatrics].
    Yanagisawa K; Hoshina H; Ichihashi H
    Jpn J Antibiot; 1983 Jun; 36(6):1271-8. PubMed ID: 6581332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamental and clinical studies of T-1982 (cefbuperazone) in the pediatric field].
    Motohiro T; Koga T; Tomita N; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Koga Y; Takajo N; Araki H; Tanaka K; Imai S; Yuasa T; Nagayama K; Tsugawa S; Tanaka Y; Shimada Y; Aramaki S; Iriki T; Cho H; Yamamoto M; Komatsu Y; Tanaka C; Yuge K; Toyoda A; Matsunaga S; Yukizane S; Takechi T; Matsuo H; Eto Y; Matsuyuki M
    Jpn J Antibiot; 1983 Apr; 36(4):888-909. PubMed ID: 6348343
    [No Abstract]   [Full Text] [Related]  

  • 5. [A comparative study between cefminox (MT-141) and cefotaxime in respiratory tract infections].
    Miki F; Inoue E; Teragaki M; Akioka K; Yoshiyama M; Hiraga T; Murata T; Saito A; Ujiie A; Abe M
    Kansenshogaku Zasshi; 1985 Feb; 59(2):115-63. PubMed ID: 3925035
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cefotetan: clinical trial in elderly persons using a single daily dose of 2 grams as the sole therapy].
    Gaillat J; Croize J; Bru JP; Stahl JP; Le Noc P; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):461-4. PubMed ID: 3534722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of cefotetan in pediatrics].
    Fujita K; Sakata H; Yoshioka H; Maruyama S; Sanae N
    Jpn J Antibiot; 1983 Jun; 36(6):1185-90. PubMed ID: 6581324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The French experience with moxalactam in pneumology].
    Leng B; Imbert Y; Coomans D
    Sem Hop; 1983 Jun; 59(26):1977-80. PubMed ID: 6310790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
    Bégué P; Safran C; Fleurette J; Brun Y; Floret D; Monnet P
    Sem Hop; 1983 Jun; 59(26):1972-6. PubMed ID: 6310789
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical studies on 6059-S in the field of pediatrics (author's transl)].
    Nagamatsu I; Takase A; Takahashi S; Ota H; Togashi K
    Jpn J Antibiot; 1981 Apr; 34(4):551-7. PubMed ID: 6457163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trial of T-1982 (cefbuperazone) in children].
    Okada T; Fukukawa S
    Jpn J Antibiot; 1983 Apr; 36(4):862-8. PubMed ID: 6876376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on 6059-S in children (author's transl)].
    Yanagisawa K; Ide K; Hoshina H; Ichihashi H
    Jpn J Antibiot; 1981 May; 34(5):757-63. PubMed ID: 6457174
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with cefotetan in the treatment of infections of children].
    Nagamatsu I; Okuno H; Takase A; Tachibana K
    Jpn J Antibiot; 1983 Jun; 36(6):1199-203. PubMed ID: 6581326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies of cefminox in the pediatric field].
    Kida K; Hayashi M; Kaino K; Matsuda H; Murase M
    Jpn J Antibiot; 1985 Mar; 38(3):751-8. PubMed ID: 3839863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of moxalactam therapy.
    Venezio FR; Westenfelder GO; Cook FV; Williams JE; Carruthers M; Reisberg BE; Emmerman J; Phair JP
    J Antimicrob Chemother; 1982 Nov; 10(5):435-43. PubMed ID: 6217184
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with cefmetazole in the urological fields].
    Tajima A; Ohmi Y; Masuda H; Ushiyama T; Fujii K; Hata M; Ohta N; Suzuki K; Fujita K; Aso Y
    Jpn J Antibiot; 1982 Aug; 35(8):1961-6. PubMed ID: 6961241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory and clinical studies of T-1982 (cefbuperazone) in pediatrics].
    Sekiguchi T; Ichioka T; Hosoda T; Masuda M; Miyao M
    Jpn J Antibiot; 1983 Apr; 36(4):869-76. PubMed ID: 6348341
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience with the use of amoxicillin in some bacterial diseases].
    Maestri G; Baraldi B; Angeli G
    Clin Ter; 1979 Sep; 90(6):541-51. PubMed ID: 535332
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Richards DM
    Drugs; 1985 Nov; 30(5):382-426. PubMed ID: 3905336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of cefotetan in complicated urinary tract infections].
    Suzuki T; Soma H; Tazawa H; Hamada W; Sugihara K; Fukushi M; Eba H
    Hinyokika Kiyo; 1987 Nov; 33(11):1917-20. PubMed ID: 3481955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.